0001562180-24-005162.txt : 20240618
0001562180-24-005162.hdr.sgml : 20240618
20240618161355
ACCESSION NUMBER: 0001562180-24-005162
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240614
FILED AS OF DATE: 20240618
DATE AS OF CHANGE: 20240618
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FRIEDMAN PAUL A
CENTRAL INDEX KEY: 0001236927
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39527
FILM NUMBER: 241051913
MAIL ADDRESS:
STREET 1: C/O INCYTE CORPORATION
STREET 2: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Prelude Therapeutics Inc
CENTRAL INDEX KEY: 0001678660
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 811384762
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 175 INNOVATION BOULEVARD
CITY: WILMINGTON
STATE: DE
ZIP: 19805
BUSINESS PHONE: (302) 467-1280
MAIL ADDRESS:
STREET 1: 175 INNOVATION BOULEVARD
CITY: WILMINGTON
STATE: DE
ZIP: 19805
FORMER COMPANY:
FORMER CONFORMED NAME: Prelude Therapeutics Inc.
DATE OF NAME CHANGE: 20160630
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2024-06-14
false
0001678660
Prelude Therapeutics Inc
PRLD
0001236927
FRIEDMAN PAUL A
C/O PRELUDE THERAPEUTICS INCORPORATED
175 INNOVATION BOULEVARD
WILMINGTON
DE
19805
true
false
false
false
false
Director Stock Option (Right to Buy)
3.90
2024-06-14
4
A
false
23500.00
0.00
A
2034-06-13
Common Stock
23500.00
23500.00
D
The option award will fully vest upon the earlier of (a) the Issuer's next annual stockholder meeting, or (b) the one-year anniversary of the grant date, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
/s/ Krishna Vaddi, Attorney-in-Fact
2024-06-18